FDA Inspection 887236 — Albemarle Corporation Process Development Center
The FDA completed an inspection of Albemarle Corporation Process Development Center on July 9, 2014 in Baton Rouge, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 9, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Baton Rouge, LA (United States)